Find out more about our COVID-19 work
Latest Work
Emerging Infections
Environmental surveillance for poliovirus
The lab tests sewage collected at sentinel sites in Australia - even negative results for poliovirus are of international significance in the fight to eradicate polio.
HIV
Examining HIV incidence in Victoria
The Nicholson group are involved in a collaborative project which aims to assess whether the introduction of PrepX in 2016 has reduced HIV incidence in Victoria.
Antimicrobial Resistance and Healthcare Associated Infections
Investigating hospital superbugs
The Stinear group is investigating the molecular basis for the increasing resistance of Staphylococcus aureaus and Enterococcus to antibiotics, and also their resistance to the cleaning agents commonly used to disinfect health care facilities.
Setting it Straight with Professor Peter Doherty
Nobel Laureate Professor Peter Doherty explores all things infection and immunity in a new weekly column, Setting it Straight, exclusive to the Doherty Institute website.
Celebrating five years - Impact report
The Peter Doherty Institute for Infection and Immunity celebrated its fifth anniversary in September 2019. Read about the history of the Institute, along with some of the highlights and impact of our work over the last five years.
Vax4COVID
Led by Vaccine and Immunisation Research Group (VIRGo) at the Doherty Institute, Vax4COVID is an alliance of experienced Australian vaccine clinical trial centres formed to facilitate the conduct of Phase II trials of SARS-CoV-2 vaccine candidates.
Meet Dr Elizabeth Aitken. A Research Officer in the Rogerson group, Elizabeth works on malaria, and has been doing so since 2006. She is currently investigating whether the innate immune response to the malaria parasite can explain why some individuals get sick while others do not.

Meet Dr David Price. David is a Biostatistics Research Fellow whose role it is to provide statistical support, covering all stages of a study from design and planning to analysis.
